Similarly, transferrin (226.90 vs. 255.90 mg/dL, p = 0.0484) and the % transferrin saturation (17.09% vs. 28.54%, p = 0.0091) were significantly reduced in the CRC group. This evidence concerns the gene TF and colorectal carcinoma.